The Automated and Closed Cell Therapy Processing Systems Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, Others), By Type (Stem Cell Therapy, Non-Stem Cell Therapy), By Scale (Pre-commercial/ R&D Scale, Commercial Scale).
The Automated and Closed Cell Therapy Processing Systems market in 2024 focuses on advancing the manufacturing and quality control processes for cell-based therapies, offering innovative solutions to streamline production, ensure product consistency, and meet regulatory requirements. Automated and closed processing systems eliminate manual handling steps and minimize contamination risks by maintaining a closed, sterile environment throughout the cell therapy manufacturing workflow. These systems encompass automated cell isolation, expansion, harvesting, and formulation platforms, as well as closed-system bioreactors, centrifugation devices, and quality control instruments tailored to the unique needs of cell therapy manufacturing facilities. With the growing demand for cell-based therapies and the increasing complexity of cellular products, automated and closed processing systems play a crucial role in scaling production, reducing costs, and accelerating time to market for novel cell therapy treatments. As biopharmaceutical companies and contract manufacturing organizations (CMOs) invest in infrastructure and automation technologies, the automated and closed cell therapy processing systems market continues to expand, driving innovation and standardization in the emerging field of cell-based medicine.
A prominent trend in the Automated and Closed Cell Therapy Processing Systems market is the increasing integration of automation and closed systems in cell therapy manufacturing processes. Automation technologies such as robotics, liquid handling systems, and computer-controlled processes are being implemented to streamline and standardize cell therapy production, reducing manual intervention and minimizing the risk of contamination. Closed systems, which prevent exposure of cell products to external environments, are also gaining traction to maintain product integrity and sterility throughout the manufacturing process. This trend towards automation and closed systems enhances efficiency, reproducibility, and compliance in cell therapy manufacturing, driving the adoption of automated and closed cell therapy processing systems.
A key driver for the Automated and Closed Cell Therapy Processing Systems market is the rising demand for scalable and reproducible cell therapy manufacturing solutions. As cell therapies transition from early-stage research to clinical and commercial applications, there is a growing need for robust manufacturing platforms that can efficiently produce large quantities of high-quality cell products. Automated and closed processing systems offer the advantages of increased throughput, standardized processes, and reduced variability, enabling manufacturers to meet the scalability and reproducibility requirements for clinical and commercial-scale production of cell therapies. The demand for these systems is further fueled by the expanding pipeline of cell-based therapies and the emphasis on manufacturing efficiency and regulatory compliance.
One potential opportunity in the Automated and Closed Cell Therapy Processing Systems market lies in the development of next-generation manufacturing technologies tailored to the unique requirements of cell therapy production. This includes the advancement of integrated and modular automated platforms capable of performing multiple manufacturing steps within a closed system, from cell isolation and expansion to formulation and packaging. By leveraging innovative technologies such as microfluidics, continuous processing, and real-time monitoring, manufacturers can enhance process control, flexibility, and scalability while minimizing manufacturing footprint and costs. Investing in the research and development of cutting-edge cell therapy manufacturing technologies presents an opportunity to address unmet needs in the field and capture market share in the evolving landscape of automated and closed cell therapy processing systems.
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
BioSpherix Ltd
Cellares Inc
Cytiva (Danaher Corp)
Fresenius Kabi
Lonza
MiltenyiBiotec
Sartorius AG
Terumo Corp
Thermo Fisher Scientific Inc
ThermoGenesis Holdings Inc
*- List Not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Automated and Closed Cell Therapy Processing Systems Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Automated and Closed Cell Therapy Processing Systems Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Automated and Closed Cell Therapy Processing Systems Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Automated and Closed Cell Therapy Processing Systems Market Size Outlook, $ Million, 2021 to 2030
3.2 Automated and Closed Cell Therapy Processing Systems Market Outlook by Type, $ Million, 2021 to 2030
3.3 Automated and Closed Cell Therapy Processing Systems Market Outlook by Product, $ Million, 2021 to 2030
3.4 Automated and Closed Cell Therapy Processing Systems Market Outlook by Application, $ Million, 2021 to 2030
3.5 Automated and Closed Cell Therapy Processing Systems Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Automated and Closed Cell Therapy Processing Systems Market Industry
4.2 Key Market Trends in Automated and Closed Cell Therapy Processing Systems Market Industry
4.3 Potential Opportunities in Automated and Closed Cell Therapy Processing Systems Market Industry
4.4 Key Challenges in Automated and Closed Cell Therapy Processing Systems Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Automated and Closed Cell Therapy Processing Systems Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Automated and Closed Cell Therapy Processing Systems Market Outlook By Segments
7.1 Automated and Closed Cell Therapy Processing Systems Market Outlook by Segments
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
8 North America Automated and Closed Cell Therapy Processing Systems Market Analysis And Outlook To 2030
8.1 Introduction to North America Automated and Closed Cell Therapy Processing Systems Markets in 2024
8.2 North America Automated and Closed Cell Therapy Processing Systems Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Automated and Closed Cell Therapy Processing Systems Market size Outlook by Segments, 2021-2030
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
9 Europe Automated and Closed Cell Therapy Processing Systems Market Analysis And Outlook To 2030
9.1 Introduction to Europe Automated and Closed Cell Therapy Processing Systems Markets in 2024
9.2 Europe Automated and Closed Cell Therapy Processing Systems Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Automated and Closed Cell Therapy Processing Systems Market Size Outlook By Segments, 2021-2030
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
10 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Automated and Closed Cell Therapy Processing Systems Markets in 2024
10.2 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Automated and Closed Cell Therapy Processing Systems Market size Outlook by Segments, 2021-2030
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
11 South America Automated and Closed Cell Therapy Processing Systems Market Analysis And Outlook To 2030
11.1 Introduction to South America Automated and Closed Cell Therapy Processing Systems Markets in 2024
11.2 South America Automated and Closed Cell Therapy Processing Systems Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Automated and Closed Cell Therapy Processing Systems Market size Outlook by Segments, 2021-2030
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
12 Middle East And Africa Automated and Closed Cell Therapy Processing Systems Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Automated and Closed Cell Therapy Processing Systems Markets in 2024
12.2 Middle East and Africa Automated and Closed Cell Therapy Processing Systems Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Automated and Closed Cell Therapy Processing Systems Market size Outlook by Segments, 2021-2030
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
BioSpherix Ltd
Cellares Inc
Cytiva (Danaher Corp)
Fresenius Kabi
Lonza
MiltenyiBiotec
Sartorius AG
Terumo Corp
Thermo Fisher Scientific Inc
ThermoGenesis Holdings Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Workflow
Separation
Expansion
Apheresis
Fill-Finish
Cryopreservation
Others
By Type
Stem Cell Therapy
Non-Stem Cell Therapy
By Scale
Pre-commercial/ R&D Scale
Commercial Scale
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Automated and Closed Cell Therapy Processing Systems Market is one of the lucrative growth markets, poised to register a 21.5% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BioSpherix Ltd, Cellares Inc, Cytiva (Danaher Corp), Fresenius Kabi, Lonza, MiltenyiBiotec, Sartorius AG, Terumo Corp, Thermo Fisher Scientific Inc, ThermoGenesis Holdings Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume